<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="/resources/stylesheets/content.css">
	<link rel="stylesheet" href="/resources/stylesheets/print.css">
	<link rel="stylesheet" href="/resources/stylesheets/font-awesome.css">

	<!-- Basic Page Needs
  ================================================== -->
    <script src="/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" async src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Musculoskeletal System</title>
	<meta name="description" content="Course Notes for Musculoskeletal System">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>

	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="/references/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div style="float: left;"><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

        <div class="course-toc">
            <div class="course-index">
                <a href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a>
            </div>
            <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, January 19</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/intro-msk.html">Introduction to the Musculoskeletal System</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/concepts-musculoskeletal-medicine.html">Concepts in Musculoskeletal Medicine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/approach-spine.html">Approach to the Spine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/anatomy-spine.html">Anatomy of the Spine</a></li></ul>
		<li class="day">Tuesday, January 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/approach-low-back-pain.html">Approach to Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/imaging-low-back-pain-radiculopathy.html">Imaging with Low Back Pain &amp; Radiculopathy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/injections-treatment-low-back-pain.html">Injections in the Treatment of Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/anatomy-lab-back-spine.html">Anatomy Lab &ndash; Back and Spine</a></li></ul>
		<li class="day">Wednesday, January 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-shoulder.html">Anatomy of the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/approach-shoulder.html">Approach to the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-posterior-shoulder.html">Anatomy Lab &ndash; Posterior Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-pec-axilla.html">Anatomy Lab &ndash; Pec/Axilla</a></li></ul>
		<li class="day">Thursday, January 22</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/brachial-plexus.html">The Brachial Plexus</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/exercise-physiology.html">Exercise Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/anatomy-lab-brachial-plexus.html">Anatomy Lab &ndash; Brachial Plexus</a></li></ul>
		<li class="day">Friday, January 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-arm.html">Anatomy of the Arm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-forearm.html">Anatomy of the Forearm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/approach-arm-elbow.html">Approach to the Arm and Elbow</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Monday, January 26</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/case-week-brachial-plexus.html">Case of the Week &ndash; Brachial Plexus Injury</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-injuries.html">Nerve Injuries</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-surgery-reconstruction.html">Nerve Surgery &amp; Reconstruction</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/anatomy-lab-anterior-forearm.html">Anatomy Lab &ndash; Anterior Forearm</a></li></ul>
		<li class="day">Tuesday, January 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-hand.html">Anatomy of the Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/work-injuries-wsib.html">Workplace Injuries and WSIB</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-lab-posterior-forearm.html">Anatomy Lab &ndash; Posterior Forearm</a></li></ul>
		<li class="day">Wednesday, January 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/approach-arm-wrist-hand.html">Approach to the Arm, Wrist & Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/msk-infections.html">MSK Infections</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/anatomy-lab-hand.html">Anatomy Lab &ndash; Hand</a></li></ul>
		<li class="day">Thursday, January 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fractures-complications.html">Fractures &amp; Complications</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fracture-imaging.html">Fracture Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/small-group-fractures.html">Fractures Small Group</a></li></ul>
		<li class="day">Friday, January 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/pharmacology-arachidonic-acid-derivatives.html">Pharmacology of Arachidonic Acid Deriatives &ndash; NSAIDs</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/cervical-soft-tissue-injuries.html">Cervical Soft Tissue Injuries</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, February 2</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/02/anatomy-lab-posterior-thigh.html">Anatomy Lab &ndash; Posterior Thigh</a></li></ul>
		<li class="day">Tuesday, February 3</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/pccm-week-1-upper-limb.html">PCCM Week 1 &ndash; Upper Limb</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/approach-hip.html">Approach to the Hip</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/anatomy-lab-anterior-medial-thigh.html">Anatomy Lab &ndash; Anterior &amp; Medial Thigh</a></li></ul>
		<li class="day">Wednesday, February 4</li>
		<ul></ul>
		<li class="day">Thursday, February 5</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/05/anatomy-lab-leg-knee.html">Anatomy Lab &ndash; Leg &amp; Knee</a></li></ul>
		<li class="day">Friday, February 6</li>
		<ul></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, February 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/09/anatomy-lab-foot-ankle.html">Anatomy Lab &ndash; Foot &amp; Ankle</a></li></ul>
		<li class="day">Tuesday, February 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-1.html">Pediatric Orthopedics I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-2.html">Pediatric Orthopedics II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/child-health-small-groups-child-limp.html">Child Health Small Groups &ndash; Limp</a></li></ul>
		<li class="day">Wednesday, February 11</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/11/common-complaints-primary-care.html">Common Complaints in Primary Care</a></li></ul>
		<li class="day">Thursday, February 12</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/12/soft-tissue-injury-small-groups.html">Soft Tissue Injuries Small Group</a></li></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Tuesday, February 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/acute-monoarthritis.html">Acute Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/chronic-monoarthritis.html">Chronic Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/small-group-monoarthritis.html">Monoarthritis Small Group</a></li></ul>
		<li class="day">Wednesday, February 18</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/acute-polyarthritis.html">Acute Polyarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatoid-arthritis.html">Rheumatoid Arthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatology-labs.html">Rheumatology Labs</a></li></ul>
		<li class="day">Thursday, February 19</li>
		<ul></ul>
		<li class="day">Friday, February 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/20/connective-tissue-disorders-1.html">Connective Tissue Disorders I</a></li></ul>
	</ul>
	<li class="week">Week 6</li>
	<ul>
		<li class="day">Monday, February 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/DMARDs-biologics.html">DMARDs &amp; Biologics</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/small-groups-polyarthritis.html">Polyarthritis Small Group</a></li></ul>
		<li class="day">Tuesday, February 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/rheumatology-review-jeopardy.html">Rheumatology Review Jeopardy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/msk-clinical-review.html">MSK Clinical Review</a></li></ul>
		<li class="day">Wednesday, February 25</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/soft-tissue-tumours.html">Soft Tissue Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/bone-tumours.html">Bone Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/small-group-bone-tumour-pathology.html">Bone Tumour Pathology Small Group</a></li></ul>
	</ul>
</nav>
        </div>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>DMARDs &amp; Biologics</h1></div>
                <info datetime="2015-02-23">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Monday, February 23, 2015</span>
                </info>
                <div class="body"><h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>

<ul>
  <li><strong>Methotrexate</strong>
    <ul>
      <li>How does methotrexate work?</li>
      <li>What are the common and important side effects of methotrexate?</li>
      <li>What routine investigations are recommended for patients taking methotrexate?</li>
      <li>How much alcohol is ok when taking methotrexate?</li>
      <li>Is methotrexate safe in pregnancy?</li>
    </ul>
  </li>
  <li><strong>Hydroxychloroquine</strong> <em>(Plaquenil)</em>
    <ul>
      <li>What are the common and important side effects of hydroxychloroquine?</li>
      <li>What routine investigations are recommended for patients taking hydroxychloroquine?</li>
    </ul>
  </li>
  <li><strong>Sulfasalazine</strong>
    <ul>
      <li>What are the common and important side effects of sulfasalazine?</li>
      <li>What routine investigations are recommended for patients taking sulfasalazine?</li>
    </ul>
  </li>
  <li><strong>Leflunomide</strong> <em>(Arava)</em>
    <ul>
      <li>What are the common and important side effects of leflunomide?</li>
      <li>What routine investigations are recommended for patients taking leflunomide?</li>
    </ul>
  </li>
  <li><strong>Biologics</strong>
    <ul>
      <li>What are the common and important side effects of the biologic agents?</li>
      <li>When should biologic agents be stopped?</li>
    </ul>
  </li>
</ul>

<h2 id="review-questions"><strong>Review Questions</strong></h2>
<ul>
  <li><em>How long do you need to wait before you start DMARD treatment?</em>
    <ul>
      <li>If it’s been present for more than 6 weeks and hasn’t been getting better.</li>
    </ul>
  </li>
  <li><em>If your RF and ANA are negative, is it still rheumatoid arthritis?</em>
    <ul>
      <li>Yes, it could still be RA.</li>
      <li>RF is negative in 50-70% of <i>early</i> cases, she will still need DMARD treatment.</li>
    </ul>
  </li>
</ul>

<h2 id="introduction-to-dmards"><strong>Introduction to DMARDs</strong></h2>
<ul>
  <li><strong>DMARDs</strong> → Disease Modifying Anti-Rheumatic Drugs.
    <ul>
      <li>It’s best to think of these medications as forms of <em>mild chemotherapy</em>.</li>
    </ul>
  </li>
  <li><em>Typically given to patients as <strong>triple therapy</strong>; a combination of multiple DMARDs.</em>
    <ul>
      <li>Historically, this hasn’t been the case. Because of worries of side-effects with ‘mild chemotherapy’, we usually waited until the symptoms became quite severe.</li>
      <li>However, now we aim to treat <i>much earlier</i>, with multiple agents in order to increase effectiveness.</li>
      <li>Triple therapy is classically described as:
        <ol>
          <li><em>Methotrexate</em></li>
          <li><em>Sulfasalazine.</em></li>
          <li><em>Hydroxychloroquine</em> (Plaquenil)</li>
        </ol>
      </li>
      <li>Sometimes <em>Leflunomide</em> is added (<i>quadruple therapy</i>).</li>
      <li>More recently, there’s a push to use methotrexate with biologics instead (depending on patient drug coverage, since biologics are $$$).</li>
    </ul>
  </li>
  <li><strong>Why do we treat earlier now?</strong>
    <ul>
      <li>This has been a paradigm shift in the treatment of inflammatory arthritis.</li>
      <li>This is mainly because <em>joint damage is an early phenomenon of rheumatoid arthritis</em>; if you wait until the inflammation gets worse, the joint damage may already be done!
        <ul>
          <li>Joint erosions occur in 93% of patients with <i>less than 2 years of disease activity.</i></li>
          <li>The rate of radiographic progression is greatest in the first 2 yeras.</li>
        </ul>
      </li>
      <li>There’s also a ‘window of opportunity’ where, if we treat heavily enough, we can actually get the disease in remission.
        <ul>
          <li>This has made the tradeoff with side-effects more bearable.</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="remember"><strong>Remember</strong></h4>
  <ul>
    <li><em>Joint damage occurs early on with RA</em>, so DMARD therapy is given earlier.</li>
    <li>It’s thought that strong treatment early on can put the disease into remission.</li>
  </ul>
</blockquote>

<h2 id="what-are-some-types-of-dmards"><strong>What are some types of DMARDs?</strong></h2>
<ul>
  <li>The <strong>main DMARDs</strong> are:
    <ol>
      <li><em>Methotrexate</em></li>
      <li><em>Sulfasalazine</em> (Salazopyrin©).</li>
      <li><em>Hydroxychloroquine</em> (Plaquenil©)</li>
      <li><em>Leflunomide</em> (Arava©)</li>
    </ol>
  </li>
  <li><em>Other DMARDs</em>, which are used less frequently, are:
    <ul>
      <li>Gold (Myochrisine©)</li>
      <li>Cyclosporine, Azathioprine, Cyclophosphamide.</li>
    </ul>
  </li>
  <li><strong>Common Drug Therapies</strong>:
    <ol>
      <li><strong>Triple Therapy</strong> → Methotrexate + Sulfasalazine + Hydroxychloroquine.</li>
      <li><em>Double Therapy</em>:
        <ul>
          <li>Methotrexate &amp; Leflunomide.</li>
          <li>Methotrexate &amp; Sulfasalazine.</li>
          <li>Methotrexate &amp; Hydroxychloroquine .</li>
          <li>Methotrexate &amp; Gold.</li>
          <li>Sulfasalazine &amp; Plaquenil.</li>
        </ul>
      </li>
      <li><em>Monotherapy</em></li>
    </ol>
  </li>
  <li>Of these, triple therapy is used (by far) the most.</li>
</ul>

<h2 id="methotrexate"><strong>Methotrexate</strong></h2>

<blockquote>
  <h4 id="objective"><strong>Objective</strong></h4>
  <ul>
    <li>How does methotrexate work?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>Mechanism of action</strong>:
    <ul>
      <li>Similarity in structure between folate and methotrexate.</li>
      <li>Competitive inhibitor of THF, interferes with purine synthesis, and thus rapidly dividing cells.</li>
      <li>Side effects relate to this; affects hair and serosa.</li>
      <li>Doesn’t work right away; takes 6-8 weeks to start working.</li>
    </ul>
  </li>
</ul>

<p>Dose and Administration  Dose ranges from 7.5 to 25 mg
 ONLY GIVEN ONCE A WEEK
 2.5 mg Tablets or Subcutaneous Injection 25 mg/mL
 Onset of Action  6-8 weeks
 Avoid
 Pregnancy – Teratogenic
 Alcohol</p>

<p> Sulfa Antibiotics (Sulfasalazine is ok)</p>

<p>Why is alcohol contraindicated?</p>

<blockquote>
  <h4 id="objective-1"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common and important side effects of methotrexate?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>Common Side Effects</strong>:
    <ul>
      <li>Malaise, nausea.</li>
      <li>Rise in liver enzymes (due to liver inflammation).</li>
    </ul>
  </li>
  <li><strong>Rare (important) Side Effects</strong>:
    <ul>
      <li>Anemia, leukopenia.</li>
      <li>Pulmonary → fever, cough, SOB.</li>
      <li>Infection, since it is an immunosupressant.</li>
      <li>Teratogenic in pregnancy.</li>
      <li>Lymphoma with long-term use.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-2"><strong>Objective</strong></h4>
  <ul>
    <li>What routine investigations are recommended for patients taking methotrexate?</li>
  </ul>
</blockquote>

<ul>
  <li><em>CBC &amp; Inflammatory markers</em> → CBC, ESR, CRP.</li>
  <li><em>Liver function tests</em> → AST, ALT, ALP, Albumin.</li>
  <li><em>Kidney function tests</em> → Creatinine.</li>
</ul>

<blockquote>
  <h4 id="objective-3"><strong>Objective</strong></h4>
  <ul>
    <li>How much alcohol is ok when taking methotrexate?</li>
  </ul>
</blockquote>

<p>Methotrexate causes inflammation of liver as well.
CAN’T DRINK ALCOHOL WHILE ON METHOTREXATE
0 -&gt; less than 1 beverage/week.
Septra is contraindicated.</p>

<blockquote>
  <h4 id="objective-4"><strong>Objective</strong></h4>
  <ul>
    <li>Is methotrexate safe in pregnancy?</li>
  </ul>
</blockquote>

<p>NO, teratogenic.</p>

<h2 id="hydroxychloroquine"><strong>Hydroxychloroquine</strong></h2>
<ul>
  <li><em>Trade name</em> → <strong>Plaquenil</strong>.</li>
  <li>Use to be anti-malarial.</li>
  <li>No one really knows how it works.</li>
  <li>Increases pH of cells.</li>
  <li>Thought that this affects ability of cells to degrade proteins. (lysozymes acidic?)</li>
</ul>

<p>Dose &amp; Administration
 200 mg tablets
 Dose ranges from 200 – 400 mg per day
 Onset
 6-12 weeks
 Avoid
 May increase sensitivity to the sun</p>

<blockquote>
  <h4 id="objective-5"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common and important side effects of hydroxychloroquine?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>Common Side Effects</strong>:
    <ul>
      <li>Rash, nausea, diarrhea.</li>
      <li><em>Affects accomodation</em> (how quickly your eye can change focus); can cause <i>difficulty with reading</i>.</li>
    </ul>
  </li>
  <li><strong>Rare (important) Side Effects</strong>:
    <ul>
      <li>Ocular, skeletal muscle, heart problems.</li>
      <li>Long term use can cause extra pigment to deposit in the back of the retina.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-6"><strong>Objective</strong></h4>
  <ul>
    <li>What routine investigations are recommended for patients taking hydroxychloroquine?</li>
  </ul>
</blockquote>

<p>No lab monitoring.
Yearly eye exams.
Plaquenil can cause extra pigment to deposit in back of retina.
Over time, can cause visual disturbances.</p>

<h2 id="sulfasalazine"><strong>Sulfasalazine</strong></h2>

<p>Developed in the late 1930s by Dr. Nana Svartz (Swedish Rheumatologist) for the treatment of “infective polyarthritis”
 Anti-inflammatory: Salicylic Acid
 Antibiotic: Sulfapyridine
 Sulfasalazine consists of salicylic acid and sulfapyridine joined by an azo bond.
 Sulfinpyradone is thought to be the active ingredient although, in RA, the mechanism of action is not understood</p>

<p>ills taken twice daily (CPS and some pharmacists – QID!)
 Start at a low dose 1 per day and gradually work up to 4 per day
 Takes 6-8 weeks to work
 Common S/E: Malaise, Nausea, Abd pain, Rash, headaches, dizziness
 Rare S/E:
 Hypersensitivity reaction
 Liver: Follow enzymes – not usually a problem
 Bone Marrow: Follow bloodwork – dose/sensitivity related  Renal: Very Rare</p>

<blockquote>
  <h4 id="objective-7"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common and important side effects of sulfasalazine?</li>
  </ul>
</blockquote>

<ul>
  <li><strong>Common Side Effects</strong>:
    <ul>
      <li>Malaise, nausea, abdominal pain, rash, headaches, dizziness.</li>
    </ul>
  </li>
  <li><strong>Rare (important) Side Effects</strong>:
    <ul>
      <li>Hypersensitivity reaction (Sulfa allergy).</li>
      <li>Liver damage → follow enzymes, usually not a problem.</li>
      <li>Bone marrow damage → follow bloodwork, dose/sensitivity related.</li>
      <li>Renal damage → very rare.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="objective-8"><strong>Objective</strong></h4>
  <ul>
    <li>What routine investigations are recommended for patients taking sulfasalazine?</li>
  </ul>
</blockquote>

<p>Exactly the same as methotrexate.
Follow liver/kidney/bone marrow. f(x).
 Lab Monitoring (week 2, 4 and then monthly)  CBC, ESR, CRP
 AST, ALT, ALP, Albumin Cr</p>

<h2 id="leflunomide"><strong>Leflunomide</strong></h2>
<ul>
  <li><em>Trade name</em> → <strong>Arava</strong>.
Inactive and converted to A177-1726 in the GI tract and liver
A77-1726 inhibits the activity of dihydro-orotate dehydrogenase, an important enzyme in the de novo synthesis of pyrimidines.
Opposite of methotrexate, which works on purines.</li>
</ul>

<p> Dose and Administration
 10 &amp; 20 mg Tablets
 Given daily – ranges from 10-20 mg per day
 Onset of Action  6-8 weeks
 Avoid
 Pregnancy – Teratogenic  Alcohol</p>

<p>NOT ONLY VERY TERATOGENIC, BUT STAYS IN BODY FOR A LONG TIME.
Need to do a complicated washout procedure before conceiving.
Similar to methotrexate.</p>

<blockquote>
  <h4 id="objective-9"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common and important side effects of leflunomide?</li>
  </ul>
</blockquote>

<p>Common S/E
 Diarrhea, nausea, malaise, hypertension, alopecia, rash
 Rare S/E
 Liver: Follow enzymes – not usually a problem
 Bone Marrow: Follow bloodwork – dose/sensitivity related  Infection
 Pregnancy
 Malignancy</p>

<p>As with methotrexate and sulfasalazine, follow liver, kidney, and BM f(x)
Both the ones that affect purine/pyrimidine f(x) highly teratogenic.</p>

<blockquote>
  <h4 id="objective-10"><strong>Objective</strong></h4>
  <ul>
    <li>What routine investigations are recommended for patients taking leflunomide?</li>
  </ul>
</blockquote>

<p> CBC, ESR, CRP
 AST, ALT, ALP, Albumin Cr</p>

<p>Same as sulfasalazine and methotrexate.</p>

<p>COMMON APPROACH</p>

<p> Triple therapy for 3-6 months
 Optimize dose and route of medications
 Incomplete Response
 Changing to sc methotrexate  Adding Leflunomide
 Adding a Biologic Agent
sc methotrexate increases absorption, reduces side-effects. Big push in canada to start with sc before oral.
Add leflunomide -&gt; quadruple.
Add biologic.</p>

<h2 id="biologics"><strong>Biologics</strong></h2>

<ul>
  <li>Roughly broken down into TNF-Alpha inhibitors and non-TNF-alpha.
Specially designed to treat inflammatory types of arthritis such as rheumatoid and psoriatic arthritis and ankylosing spondylitis.
 Six biologics currently available (and <i>lots</i> more coming)
 Work by different mechanisms.
 Like DMARDs, biologics are used to suppress inflammation and help prevent damage to the joint.</li>
</ul>

<hr />

<p>TNF Inhibitors
	 Adalimumab (Humira) 
	 Etanercept (Enbrel)
	 Infliximab (Remicade) 
	 Golimumab (Simponi) 
	 Certolizumab (Cimzia)
 IL-1 Inhibitors 
	 Anakinra (Kineret)
 IL6 Inhibitors
	 Tocilizumab (Actemra)
 T-Cell Co-Stimulatory Blockade 
	 Abatacept (Orencia)
 B-Cell Depletion 
	 Rituximab (Rituxan)</p>

<p>In some people with arthritis, a protein called Tumour Necrosis Factor (TNF) is present in the blood and joints in excessive amounts where it increases inflammation (pain &amp; swelling).</p>

<p>How to TNF-inhibitors work?
Block inflammatory cascade.
 Mechanism of Action
 Infliximab and Adalimumab are antibodies directed against TNF  Etanercept is a soluble receptor decoy!!
 Administration
 Infliximab is given intravenously
 Etanercept, Adalimumab, Golimumab, &amp; Certolizumab are all given by subcutaneous injection</p>

<p>MAB = monoclonal AB.
Cept = re<em>cept</em>or blocer.</p>

<blockquote>
  <h4 id="objective-11"><strong>Objective</strong></h4>
  <ul>
    <li>What are the common and important side effects of the biologic agents?</li>
  </ul>
</blockquote>

<p>TNF INHIBITION.
Infusion Reactions with Infliximab, Injection Site Reactions with Adalimumab and Etanercept
 Infection
 Tuberculosis
 Serious resulting in death
 Malignancy
 Increased risk of melanoma ?lymphoma
	- Might be due to by indication (?) people with RA already at increased risk of lymphoma.
 Neurologic
 Multiple Sclerosis, seizures, inflammation of the ocular nerve
 Autoimmune
 Antibody formation – SLE like illness
 Worsening of Congestive Heart Failure</p>

<hr />

<p>How to T-Cell Co-Stimulatory Blockades work?
T cell needs 2 signals: 1 from APC, and 1 from MHC.
Orencia blocks the costimulatory signal and prevents it from activating.
Anti CD-80, 86 receptor.</p>

<p>Given on week 0, 2, and 4 then every 4 weeks  Quick infusions over 30 minutes
 Well tolerated
 Home infusion program</p>

<p>Side Effects
 INFEC TION
 COPD Exacerbation
 MALIGNANC Y – Lung Cancer  Infusion Reactions – Rare</p>

<p><img src="/images/m62d2tk8.png" /></p>

<blockquote>
  <h4 id="objective-12"><strong>Objective</strong></h4>
  <ul>
    <li>When should biologic agents be stopped?</li>
  </ul>
</blockquote>

<p>STOP if develop a fever, have an infection, or have been prescribed antibiotics
 Tell your doctor about any upcoming surgeries</p>

<p>LUPUS + RA = RUPUS!?! :P
Started as a joke, now the actual name.</p>

<hr />
<p>B-Cell Depletion (Rituximab)
(I GIVE UP HERE)
RA was thought to be T-Cell mediated  Most widely accepted hypothesis:
 Professional Antigen Presenting Cell encounters some “unknown” antigen
 It presents this “unknown” antigen to a CD4 T-helper Cell
 In a genetically predisposed individual, this starts an immune
chain reaction
 Immune system is confused and targets healthy tissue</p>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/musculoskeletal/2015/02/20/connective-tissue-disorders-1.html"><i class="fa fa-angle-left"></i> Connective Tissue Disorders I</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/small-groups-polyarthritis.html">Polyarthritis Small Group <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/musculoskeletal/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="/resources/stylesheets/search.css">	
<script src="/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>